Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycin With Amoxicillin/Clavulanate Versus Amoxicillin/Clavulanate Alone in COVID-19 Patients With Pneumonia and Hospitalized in a Non-intensive Care Unit Ward (AziA): a Superiority Open-label Randomized Controlled Trial

NCT04363060 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04363060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04363060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycin With Amoxicillin/Clavulanate Versus Amoxicillin/Clavulanate Alone in COVID-19 Patients With Pneumonia and Hospitalized in a Non-intensive Care Unit Ward (AziA): a Superiority Open-label Randomized Controlled Trial
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2020
Completion date
July 30, 2020
Enrollment
104 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia